Clinical Trial Update: Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 clinical trial investigating a combination of gefitinib and sirolimus for recurrent or refractory stage IIIB/IV non-small cell lung cancer has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)
• Rapamune (sirolimus)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: WITHDRAWN